Alto Neuroscience, Inc. Earnings
The next earnings date for Alto Neuroscience, Inc. is November 18, 2025.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Alto Neuroscience, Inc. Earnings
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Alto Neuroscience, Inc. Earnings: Historical
More About Alto Neuroscience, Inc.
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
“Alto Neuroscience, Inc. Earnings” Can Refer to the Alto Neuroscience, Inc. Earnings Date
Some people say “Alto Neuroscience, Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Alto Neuroscience, Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Alto Neuroscience, Inc. Stock on the Earnings Date
If you own Alto Neuroscience, Inc. stock (ANRO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Alto Neuroscience, Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Alto Neuroscience, Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Alto Neuroscience, Inc. Earnings
You can contact us any time if you would like to ask questions about Alto Neuroscience, Inc. earnings or anything else related to the stock market.